ICD therapy: what have we learned from the clinical trials?

Area of Science:

• Cardiology
• Medical Devices
• Clinical Trials

Background:

• Implantable cardioverter defibrillators (ICDs) represent a major breakthrough in managing life-threatening ventricular arrhythmias.
• Effective patient selection and appropriate use are crucial for maximizing ICD benefits.

Purpose of the Study:

• To review landmark clinical trials on ICDs.
• To emphasize the impact of late-breaking clinical trials on current clinical practice.
• To assess how trial evidence influences daily decision-making and patient selection for ICD implantation.

Main Methods:

• Systematic review of pivotal and late-breaking clinical trials concerning ICDs.
• Analysis of trial outcomes and their translation into clinical guidelines.
• Evaluation of the impact on physician decision-making and patient management.

Main Results:

• Landmark trials have established the efficacy of ICDs in reducing mortality for specific patient groups.
• Late-breaking trials continue to refine patient selection criteria and indications for ICDs.
• Evidence from trials directly impacts everyday clinical decisions regarding ICD therapy.

Conclusions:

• ICDs are a cornerstone in managing ventricular arrhythmias, supported by robust clinical trial data.
• Ongoing evaluation of clinical trials is essential for optimizing ICD implantation strategies.
• Clinical trial evidence is pivotal for informed patient selection and effective ICD therapy.